000			01974nam a22004453i 4500
001			EBC3379436
003			MiAaPQ
005			20240729125355.0
006			m o d |
007			cr cnu||||||||
008			240724s2015 xx o ||||0 eng d
020			_a9780309368407 _q(electronic bk.)
035			_a(MiAaPQ)EBC3379436
035			_a(Au-PeEL)EBL3379436
035			_a(CaPaEBR)ebr11042784
035			_a(OCoLC)923291273
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aT174.5 -- .I578 2014eb
082	0		_a363.1
100	1		_aMedicine, Institute of.
245	1	0	_aCharacterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : _bWorkshop in Brief.
250			_a1st ed.
264		1	_aWashington : _bNational Academies Press, _c2015.
264		4	_c©2014.
300			_a1 online resource (8 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aCharacterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products-Workshop in Brief.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aRisk assessment -- Congresses.
650		0	_aCommunication -- Congresses.
655		4	_aElectronic books.
700	1		_aPolicy, Board on Health Sciences.
700	1		_aForum on Drug Discovery, Development, and Translation.
776	0	8	_iPrint version: _aMedicine, Institute of _tCharacterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products _dWashington : National Academies Press,c2015
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3379436 _zClick to View
999			_c86715 _d86715